Here are the references for the second episode of our series on the history of UK drug use in the 1950s and 1960s, Pharmaceutical Marketing.
The list is seperated between general material I used, medical articles - Largely from the British Medical Journal (BMJ) and the British Journal of Addiction (BJA), newspaper articles and House of Commons Debates (HCD) from Hansard.
A transcript for this episode can be found here.
General Sources
'What drugs work best for ADHD?', NHS.uk, 2018.
Anderson, S., 'Drug regulation and the Welfare State', in Medicine, the market and the mass media: Producing health in the twentieth century, (Berridge, V. and Loughlin, K. eds.), (London: 2005).
Braithwaite, J., Corporate crime in the pharmaceutical industry, (London: 1984).
Clayton, D., ‘Advertising expenditure in 1950s Britain’, Business History, 2010, Vol. 52, No. 4, pp. 651-665.
Inglis, B., Drugs, doctors and disease, (1965: London).
Lehamann, H., The Impact of the Psychopharmacological Revolution on psychiatry, (Toronto: 1986).
Tobbell, D., ‘"Who's winning the human race?" Cold War as pharmaceutical political strategy’, Journal of the History of Medicine and Allied Sciences, 2009, Vol. 64, No. 4, pp. 429-473.
Medical Journals
‘Dangers of efocaine’, BMJ,1954, Vol 1. No. 4867, p.926.
‘Discussion following the papers on tranquillizers’, BJA,1958, Vol. 54, No. 2, pp. 5-7.
'Front matter', BMJ, 1955, Vol. 1, No.4927, pp. 11-44.
‘Front matter’, BMJ, 1957, Vol. 2, No. 5038, pp. 10-44.
‘Symposium on tranquilizers’, BMJ,1957, Vol. 2, No. 5038, pp. 219-221.
Dent, J.,‘Editorial’, BJA,1958, Vol. 54, No. 2, pp. 79-80.
Inch, R., ‘The Pharmaceutical industry’, BMJ, 1958, Vol. 2, No. 5100, pp. 846-849.
Kohn, J., Rutter, A., Vitali, M., ‘Prolonged local analgesia with benzocaine-urethane solution’, BMJ, 1954, Vol. 2, No. 4889, pp. 682-684.
Macdonald, A. ‘Some mood-modifying drugs and their possible abuse’, BJA, 1957, Vol. 53, No. 2, pp. 75-82
Oldham, J., ‘Reduction of post-operative pain’ BMJ, 1953, Vol. 2, No. 4835, p. 570.
Park, M., ‘Correspondence: New Drugs’, BMJ, 1958, Vol. 2, No. 5093, pp. 122-123.
Parker, L., Williams, J., Bero, L., ‘Ethical drug marketing criteria for the 21stcentury’, BMJ, 2018, Vol. 361, No. 8151.
Parsonage, M., Taverner, D. and Wooler, G., Paraplegia following the use of “Efocaine”, BMJ,1955, Vol. 1, No. 4925, pp. 1322-1323.
Roualle, H.,‘Prolonged wound analgesia after surgical operations: Clinical trial of Efocaine’ BMJ, 1952, Vol. 2, No. 4797, pp. 1293-1295.
Wilkins, E., ‘A drug advertisement’, BMJ, 1961, Vol.2, No.5258, p. 1026.
Williams, M., 'Letters to the editor: Industry and profession', Lancet, 1961, Vol. 278, No. 7201, pp. 554-556.
Newspaper Articles
‘The art of medicine in a drug-conscious age: Demands on the doctor’, Guardian, 23 November 1953.
‘Selling to doctors’, Guardian, 10 December 1959. P. 18.
‘Sweet music’, Daily Mirror,1 May 1958. P. 2.
‘Wonder drug kills pain after operations’, Daily Mail, 8 January 1953.
House of Commons Debates
Noel-Baker, F., HCD, 21 November 1958, vol. 595, col. 1515-1519.
Summerskill, E.,HCD, 30 July 1956, vol. 557, col. 913-914.
Summerskill, E.,HCD, 30 July 1958, vol. 592, col. 1474-1481.